Rallybio Corporation (RLYB) — Financial statements
Income statement, balance sheet, and cash flow for Rallybio Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.86↑34.9% | 0.64 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.09 | 0.00↓100.0% | 0.15↓10.2% | 0.17↑53.2% | 0.11 | |
| Gross Profit | 0.77↑20.4% | 0.64↑524.0% | -0.15↑10.2% | -0.17↓53.2% | -0.11 | |
| Operating Expenses | ||||||
| R&D Expenses | 20↓52.8% | 42↓22.5% | 54↑31.6% | 41↑51.2% | 27 | |
| General & Administrative Expenses | 14↓27.0% | 20↓22.7% | 25↓6.6% | 27↑45.1% | 19 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 14↓27.0% | 20↓22.7% | 25↓6.6% | 27↑45.1% | 19 | |
| Other Expenses | -5 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 29↓52.8% | 61↓22.6% | 79↑16.3% | 68↑48.7% | 46 | |
| Total Costs & Expenses | 29↓52.7% | 61↓22.6% | 79↑16.3% | 68↑48.7% | 46 | |
| Operating Results | ||||||
| Operating Income | -28↑53.6% | -60↑23.4% | -79↓16.3% | -68↓48.7% | -46 | |
| Depreciation & Amortization | 0.09↓29.8% | 0.13↓12.7% | 0.15↓10.2% | 0.17↑53.2% | 0.11 | |
| EBITDA | -28↑53.7% | -60↑23.4% | -79↓16.3% | -68↓49.2% | -45 | |
| EBIT | -28↑53.6% | -60↑23.4% | -79↓16.3% | -68↓49.2% | -45 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↓48.1% | 4↓31.4% | 6↑213.1% | 2↑4361.4% | 0.04 | |
| Interest Income | 2↓48.1% | 4↓31.4% | 6↑213.1% | 2↑3535.2% | 0.05 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.01 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.15 | |
| Other Income / Expenses | 19↑601.4% | 3↓37.7% | 4↑255.1% | 1↑190.1% | -1 | |
| Income Before Tax | -9↑84.5% | -58↑22.5% | -75↓10.1% | -68↓44.1% | -47 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00↑100.0% | -1 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -9↑84.5% | -58↑22.5% | -75↓11.9% | -67↓41.8% | -47 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -9↑84.5% | -58↑22.5% | -75↓11.9% | -67↓41.8% | -47 | |
| Bottom-Line Net Income | -9↑84.5% | -58↑22.5% | -75↓11.9% | -67↓41.8% | -47 | |
| EPS (Basic) | -1.59↑85.1% | -10.64↑27.7% | -14.72↑12.0% | -16.72↓43.2% | -11.68 | |
| EPS (Diluted) | -1.59↑85.1% | -10.64↑27.7% | -14.72↑12.0% | -16.72↓43.2% | -11.68 | |
| Weighted Average Shares | 6↑3.4% | 5↑7.7% | 5↑27.1% | 4↓1.0% | 4 | |
| Weighted Average Diluted Shares | 6↑3.4% | 5↑7.7% | 5↑27.1% | 4↓1.0% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.